Wound healing and skin disease

---

Henrik Lund

Regenics AS, Norway

: J Regen Med

Abstract

---

     

Biography

---

Henrik Lund joined Regenics in 2014. Lund is an MD PhD from University of Oslo and received his post-doctoral training at UC San Francisco in lipidology. In 2005 – 2010 Lund served as VP of AstraZeneca's Marketing Company clinical development group. He has also served as CEO and Chairman of the Board of several Norwegian biotech/life science companies and is at present Chairman Board of Directors Oslo Cancer Cluster, NCE. Lund works as CEO for Regenics from his own consultancy company.

E-mail: henrik.lund@regenics.no